Venlafaxine Hydrochloride
Product Images NDC 70934-349

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70934-349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 349 30 Rev A 05 19)

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, containing 30 capsules. The label states the product is by Denton Pharma, Inc. DBA Northwind Pharmaceuticals, with NDC 70934-349-30. The label includes storage instructions, dosage reference, lot number, expiration date placeholders, and warnings to keep out of reach of children and to store in original container.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 01)

A chart showing the pharmacokinetic fold changes and 90% confidence interval recommendations for venlafaxine hydrochloride when interacting with various drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The graph plots Cmax and AUC values relative to reference, with adjustments or cautions noted for each interacting drug.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 02)

A forest plot chart showing pharmacokinetic fold changes and 90% confidence intervals of various analytes of interacting drugs relative to a reference value. The chart includes interacting drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium, with recommendations for dose adjustment or caution noted on the right side.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 03)

A scatter plot chart presenting fold changes and 90% confidence intervals for venlafaxine and its metabolite ODV pharmacokinetics (Cmax and AUC) across different special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age, and gender. The chart shows relative changes compared to a reference value with dosage recommendations on the right side.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 04)

Chemical structure of venlafaxine hydrochloride depicting its molecular composition including a cyclohexane ring, hydroxyl group, and dimethylaminoethyl side chain, with a hydrochloride (HCl) moiety indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.